(CPSP.L) Clyde Process Solutions PLC Buy/Sell

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying Clyde Process Solutions plc

issuer of existing shares to which voting rights are attached: ii

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify):

3. Full name of person(s) subject to Lloyds Banking Group plc

the notification obligation: iii
4. Full name of shareholder(s) (if See Section 9.

different from 3.):iv
5. Date of the transaction and date 7 October 2009

on which the threshold is crossed or reached: v
6. Date on which issuer notified: 8 October 2009

7. Threshold(s) that is/are crossed Direct/Indirect increase to above 11%

or reached: vi, vii

8. Notified details: A: Voting rights attached to shares viii, ix

Class/type of Situation previous Resulting situation after
shares to the triggering the triggering
transaction transaction

if possible Number Number Number Number of % of voting
using of of of shares voting rights x
the ISIN CODE Shares Voting rights
Rights

Direct Direct xi Indirect Direct Indirect
xii

Ord 25p 4,229,921 4,229,921 3,101,588 3,101,588 1,563,965 7.682% 3.873%

Shares

GB00B1TSKR82

B: Qualifying Financial Instruments Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date xiii Conversion Period rights that may be rights
xiv acquired if the
instrument is
exercised/
converted.

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi Resulting situation after the triggering transaction
Type of Exercise Expiration Exercise/ Number of voting % of voting
financial price date xvii Conversion rights instrument rights xix, xx
instrument period refers to
xviii

Nominal Delta

Total (A+B+C)
Number of voting rights Percentage of voting rights

4,665,553 11.555%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi 2,669,601 shares (6.612%) are under the control of Uberior Equity Limited, a wholly owned subsidiary of Uberior Investments plc, a wholly owned subsidiary of Bank of Scotland plc, a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc (Direct Interests). 1,995,940 shares (4.943%) are under the control of Insight Investment Management (Global) Limited, a wholly owned subsidiary of Insight Investment Management Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited, a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc (Indirect Interests). Within these holdings 29,213 shares (0.072%) are managed on behalf of Clerical Medical Managed Funds Limited a wholly owned subsidiary of Clerical Medical Investment Group Limited, and a further 402,762 shares (0.998%) are managed on behalf of Clerical Medical Investment Group Limited, a wholly owned subsidiary of HBOS Financial Services Limited, a wholly owned subsidiary of HBOS Insurance & Investment Group Limited a wholly owned subsidiary of HBOS plc, a wholly owned subsidiary of Lloyds Banking Group plc, These holdings are therefore disclosed as an overall Direct Interest.

Proxy Voting:
10. Name of the proxy holder: N/A

11. Number of voting rights proxy N/A

holder will cease to hold:
12. Date on which proxy holder will N/A

cease to hold voting rights:

13. Additional information: Notification using the Total Voting
Rights figure of 40,376,710

14. Contact name: Kenny Melville

15. Contact telephone number: 0131 243 5301

END